LENSAR, Inc. (LNSR): Price and Financial Metrics


LENSAR, Inc. (LNSR): $8.23

-0.13 (-1.56%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

LNSR Stock Price Chart Interactive Chart >

Price chart for LNSR

LNSR Price/Volume Stats

Current price $8.23 52-week high $12.71
Prev. close $8.36 52-week low $3.16
Day low $8.15 Volume 48,800
Day high $8.30 Avg. volume 36,087
50-day MA $7.72 Dividend yield N/A
200-day MA $0.00 Market Cap 89.98M

LENSAR, Inc. (LNSR) Company Bio


LENSAR, Inc. develops laser technologies. The Company provides autoprecision laser and proprietary 3-D imaging, measurement, and guidance system for refractive cataract surgery. LENSAR serves the healthcare industries throughout the United States.


LNSR Latest News Stream


Event/Time News Detail
Loading, please wait...

LNSR Latest Social Stream


Loading social stream, please wait...

View Full LNSR Social Stream

Latest LNSR News From Around the Web

Below are the latest news stories about LENSAR Inc that investors may wish to consider to help them evaluate LNSR as an investment opportunity.

LENSAR Reports First Quarter 2021 Financial Results and Provides Business Update

LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the first quarter ended March 31, 2021 and provided an update on key strategic and operational initiatives.

Yahoo | May 5, 2021

LENSAR Inc to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 5, 2021 / LENSAR Inc (NASDAQ:LNSR) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 5, 2021 at 8:30 AM Eastern Time.To listen to the event live or access a replay of the call - visit https://www.

Yahoo | May 5, 2021

LENSAR to Hold First Quarter 2021 Financial Results Conference Call on Wednesday, May 5, 2021

LENSAR, Inc. (NASDAQ: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s first quarter 2021 financial results will be released before market open on Wednesday, May 5, 2021. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Wednesday, May 5, 2021 to discuss the financial results and recent corporate highlights.

Yahoo | April 28, 2021

LENSAR Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the fourth quarter and full year ended December 31, 2020 and provided an update on key strategic and operational initiatives.

Yahoo | March 10, 2021

LENSAR to Hold Fourth Quarter and Full Year 2020 Financial Results and Business Update Conference Call on Wednesday, March 10, 2021

LENSAR, Inc. (NASDAQ: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s fourth quarter and full year 2020 financial results will be released before market open on Wednesday, March 10, 2021. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Wednesday, March 10, 2021 to discuss the financial results and recent corporate highlights.

Yahoo | March 3, 2021

Read More 'LNSR' Stories Here

LNSR Price Returns

1-mo 4.31%
3-mo -0.84%
6-mo 13.05%
1-year N/A
3-year N/A
5-year N/A
YTD 13.52%
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7007 seconds.